In 2009 ALS-associated mutations were discovered in Fused in Sarcoma (FUS) (Kwiatkowski et al., 2009), which encodes a nucleic acid binding protein with roles including transcriptional regulation, and response to DNA damage by recruitment of DNA repair factors (Wang et al., 2013). This evidence concerns the gene FUS and amyotrophic lateral sclerosis.